DocGo (DCGO) Morgan Stanley 24th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 24th Annual Global Healthcare Conference summary
16 Sep, 2026Business overview and growth strategy
Provides mobile health, medical transportation, and telehealth services across the U.S. and U.K., with 700,000 patient transports and 1 million telehealth visits annually.
Focuses on chronic condition management, remote monitoring 55,000 patients, and in-home care for 150,000 patients per year.
Integrated tech platform matches clinicians and diagnostics to patient needs, optimizing care delivery both virtually and in-person.
Recent acquisitions, such as PTI and SteadyMD, have expanded capabilities in mobile phlebotomy and virtual care, with strong year-over-year revenue growth.
Market expansion is driven by anchor customers and embedded demand, prioritizing profitability and integration with existing workflows.
Profitability and financial targets
Targets adjusted EBITDA positivity by year-end, with $240 million of projected 2026 revenue from currently profitable business lines.
Non-profitable service lines are being eliminated or redesigned, with ongoing efforts to optimize gross margin from 30.5% to 34%.
SG&A reductions include a $3 million quarterly cut and a major RIF, aiming for a profitable run-rate by year-end.
Automation and AI initiatives are expected to save $6 million on SG&A, focusing on non-clinical administrative tasks.
Capital allocation prioritizes tech investment, debt reduction, and maintaining existing fleet over new CapEx.
Hicuity Health acquisition and integration
Acquiring Hicuity Health, a virtual care platform specializing in tele-ICU and virtual nursing, to enhance hospital-to-home care continuity.
Hicuity brings $65 million in revenue and $4.5 million adjusted EBITDA, with further synergies expected post-integration.
$52 million in assumed debt, with up to $100 million in available funding; debt service plans include profitability, receivables collection, and potential asset sales.
Integration aims to reduce hospital readmissions and provide value to hospitals and insurers by bridging care transitions.
A deep-dive webinar on integration plans and growth vectors is scheduled for later in the month.
Latest events from DocGo
- Q2 2026 revenue reached $73.4M, with strong growth and a major virtual care acquisition planned.DCGO
Investor presentation - Q2 2026 revenue fell 8.7% but core lines grew 19% as net loss widened to $18.0M.DCGO
Q2 2026 - Record growth, board transition, and tech-driven initiatives mark a pivotal year.DCGO
AGM 2026 - Transitioning to proactive, tech-enabled care, the company targets growth and profitability.DCGO
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Tech-driven healthcare platform posts strong growth, raises guidance, and targets profitability.DCGO
21st Annual Needham Technology, Media, & Consumer Conference - Rapidly scaling mobile healthcare and transport with strong growth, tech integration, and expanding margins.DCGO
Investor presentation - Q1 revenue was $75.6M, net loss widened, but 2026 guidance was raised on strong core growth.DCGO
Q1 2026 - Q3 revenue dropped 26%, but net income and adjusted EBITDA rose, with guidance raised.DCGO
Q3 2024 - Q2 revenue up 31% to $164.9M, net income and margins rose, cash flow guidance increased.DCGO
Q2 2024